首页> 外文期刊>Retina >Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion: 63 consecutive cases.
【24h】

Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion: 63 consecutive cases.

机译:放射状视神经切开术联合眼内曲安奈德治疗视网膜中央静脉阻塞:连续63例。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Central retinal vein occlusion (CRVO) is a leading cause of permanent retinal vascular blindness. In a previous communication the authors reported the results of radial optic neurotomy (RON) in 117 consecutive patients with severe CRVO. Persistent cystoid macular edema (CME) and macular pigmentation (MP) were observed and correlated with worse macular function. Intraocular triamcinolone (IOK) has been used to treat patients with CME and CRVO. The authors performed RON with simultaneous, adjunctive IOK (RON/IOK) in patients with CRVO to ascertain any anatomic or visual benefit of this combined approach. METHODS: Pars plana vitrectomy and RON were performed on a case-by-case basis on 63 consecutive patients with CRVO and visual acuity of 20/200 or worse. At the end of the case, 4 mg of triamcinolone was injected into the vitreous cavity (RON/IOK). Patients were observed with serial fundus photographs, fluorescein angiography (FA), Snellen visual acuity (VA), intraocular pressures (IOP), and biomicroscopy for anterior segment neovascularization (ANV). Anatomic and visual outcomes were compared to a previous series of 117 patients with severe CRVO undergoing RON alone. RESULTS: Clinical improvement as determined by fundus examination, photography, and FA was noted in 93% of patients following RON/IOK. Snellen VA improved by an average of three lines (range one to seven) in 68% of all patients. Two or more lines were gained in 44% of patients and four or more lines were gained in 20% of patients. ANV developed in 7% of patients following RON/IOK. Persistent CME and MP were noted in 17% and 28% of patients, respectively. These outcomes were similar to patients undergoing RON alone without IOK. Elevated IOP was noted in 25% of patients and one patient developed endophthalmitis following RON/IOK. CONCLUSIONS: Surgical decompression of CRVO via RON/IOK is a technically feasible procedure. Clinical resolution of the CRVO and improved visual function noted in RON/IOK paralleled outcomes following RON alone. RON/IOK was associated with a higher incidence of elevated IOP and endophthalmitis.
机译:目的:视网膜中央静脉阻塞(CRVO)是永久性视网膜血管失明的主要原因。在先前的通讯中,作者报告了连续117例严重CRVO患者的放射状视神经切开术(RON)的结果。观察到持续性囊样黄斑水肿(CME)和黄斑色素沉着(MP),并与黄斑功能恶化相关。眼内曲安奈德(IOK)已用于治疗CME和CRVO患者。作者对CRVO患者同时进行RON和辅助IOK(RON / IOK),以确定这种联合治疗方法在解剖学或视觉方面的益处。方法:对63例连续CRVO且视敏度为20/200或更差的患者进行逐例玻璃体玻璃体切除术和RON。在这种情况下,将4 mg曲安西龙注射入玻璃体腔(RON / IOK)。观察患者的连续眼底照片,荧光血管造影(FA),Snellen视力(VA),眼压(IOP)和生物显微镜检查前段新血管形成(ANV)。将解剖学和视觉结果与先前的117例严重CRVO仅接受RON的患者进行了比较。结果:RON / IOK术后93%的患者通过眼底检查,摄影和FA改善了临床状况。 68%的患者中,Snellen VA平均改善了三行(范围从一到七)。在44%的患者中获得了两个或更多行,在20%的患者中获得了四个或更多行。 RON / IOK后有7%的患者出现ANV。分别在17%和28%的患者中发现了持续性CME和MP。这些结果与单独行RON而无IOK的患者相似。 RON / IOK后有25%的患者观察到IOP升高,一名患者发展为眼内炎。结论:通过RON / IOK手术对CRVO减压是一种技术上可行的方法。 RON / IOK中记录的CRVO的临床分辨率和视觉功能的改善与RON单独治疗后的预后相似。 RON / IOK与更高的IOP和眼内炎发病率相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号